Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-09-30 4:42 pm Unchanged | 13D | CYTEIR THERAPEUTICS INC CYT | Novo Holdings A/S | 3,940,413 11.1% | 0 (Unchanged) | View |
| 2022-08-15 5:06 pm Sale | 13G | CYTEIR THERAPEUTICS INC CYT | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,350,506 (Position Closed) | View |
| 2022-07-22 6:37 pm Sale | 13D | CYTEIR THERAPEUTICS INC CYT | Novo Holdings A/S | 3,940,413 11.1% | -900,000 (-18.59%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | RA CAPITAL MANAGEMENT L.P. | 3,350,506 9.5% | 103,389 (+3.18%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | Venrock Associates VII L.P. | 3,259,022 9.2% | 3,259,022 (New Position) | View |
| 2022-02-14 4:02 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | Lightstone Ventures II L.P. | 2,444,265 6.9% | 2,444,265 (New Position) | View |
| 2022-02-11 6:07 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | Avidity Partners Management LP | 1,849,538 5.2% | 1,849,538 (New Position) | View |
| 2022-02-11 3:29 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | JANUS HENDERSON GROUP PLC JHG | 1,872,421 5.3% | 1,872,421 (New Position) | View |
| 2022-02-09 09:11 am Sale | 13G | CYTEIR THERAPEUTICS INC CYT | FMR LLC | 4,048,993 11.447% | -236,666 (-5.52%) | View |
| 2022-02-03 4:45 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | Osage University GP II LLC | 2,474,572 7% | 2,474,572 (New Position) | View |
| 2021-12-20 1:00 pm Unchanged | 13D | CYTEIR THERAPEUTICS INC CYT | Novo Holdings A/S | 4,840,413 13.6% | 0 (Unchanged) | View |
| 2021-10-12 09:25 am Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | FMR LLC | 4,285,659 12.116% | 4,285,659 (New Position) | View |
| 2021-06-29 4:33 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | RA CAPITAL MANAGEMENT L.P. | 3,247,117 9.4% | 3,247,117 (New Position) | View |
| 2021-06-25 4:33 pm Purchase | 13D | CYTEIR THERAPEUTICS INC CYT | Novo Holdings A/S | 4,840,413 14% | 4,840,413 (New Position) | View |